SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 15-12B - Securities registration termination [Section 12(b)]:
SEC Accession No. 0001193125-21-300050
Filing Date
2021-10-15
Accepted
2021-10-15 16:19:01
Documents
1
Effectiveness Date
2021-10-15

Document Format Files

Seq Description Document Type Size
1 15-12B d235902d1512b.htm 15-12B 10460
  Complete submission text file 0001193125-21-300050.txt   11488
Mailing Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601 844-445-5704
XERIS PHARMACEUTICALS INC (Filer) CIK: 0001346302 (see all company filings)

IRS No.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 15-12B | Act: 34 | File No.: 001-38536 | Film No.: 211326276
SIC: 2834 Pharmaceutical Preparations